Kleiman, N S <br/><br/>
Mechanisms of early death despite thrombolytic therapy: experience from the Thrombolysis in Myocardial Infarction Phase II (TIMI II) study.  [electronic resource] 

 -  Journal of the American College of Cardiology  May 1992 
 - 1129-35 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0735-1097 
<br/><br/><label>Standard No.: </label>10.1016/0735-1097(92)90313-c  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic beta-Antagonists--administration & dosage<br/>Cause of Death<br/>Chi-Square Distribution<br/>Drug Evaluation<br/>Humans<br/>Infusions, Intravenous<br/>Myocardial Infarction--drug therapy<br/>Prognosis<br/>Recombinant Proteins--administration & dosage<br/>Survival Rate<br/>Thrombolytic Therapy<br/>Time Factors<br/>Tissue Plasminogen Activator--administration & dosage<br/>United States